Early remdesivir to prevent severe COVID-19 in recipients of solid organ transplant: a real-life study from Northern Italy

OBJECTIVES: The effectiveness of a 3-day course of remdesivir to prevent severe disease in patients with COVID-19 who received solid organ transplant (SOT) is unknown. We wanted to study the efficacy of this therapeutic option in patients with COVID-19 who received SOT in preventing both hospitaliza...

Descripción completa

Detalles Bibliográficos
Autores principales: Colaneri, Marta, Amarasinghe, Nicolò, Rezzonico, Leonardo, Pieri, Teresa Chiara, Segalini, Emilio, Sambo, Margherita, Roda, Silvia, Meloni, Federica, Gregorini, Marilena, Rampino, Teresa, Pelenghi, Stefano, Ricciardi, Alessandra, Bruno, Raffaele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9076039/
https://www.ncbi.nlm.nih.gov/pubmed/35533831
http://dx.doi.org/10.1016/j.ijid.2022.05.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9076039/
https://www.ncbi.nlm.nih.gov/pubmed/35533831
http://dx.doi.org/10.1016/j.ijid.2022.05.001

Ejemplares similares